Literature DB >> 12892562

Stable dimeric assembly of the second membrane-spanning domain of CFTR (cystic fibrosis transmembrane conductance regulator) reconstitutes a chloride-selective pore.

Mohabir Ramjeesingh1, Francisca Ugwu, Canhui Li, Sonja Dhani, Ling Jun Huan, Yanchun Wang, Christine E Bear.   

Abstract

Structural information is required to define the molecular basis for chloride conduction through CFTR (cystic fibrosis transmembrane conductance regulator). Towards this goal, we expressed MSD2, the second of the two MSDs (membrane-spanning domains) of CFTR, encompassing residues 857-1158 in Sf9 cells using the baculovirus system. In Sf9 plasma membranes, MSD2 migrates as expected for a dimer in non-dissociative PAGE, and confers the appearance of an anion permeation pathway suggesting that dimeric MSD2 mediates anion flux. To assess directly the function and quaternary structure of MSD2, we purified it from Sf9 cells by virtue of its polyhistidine tag and nickel affinity. Reconstitution of MSD2 into liposomes conferred a 4,4'-di-isothiocyanostilbene-2,2'-disulphonate-inhibitable, chloride-selective electrodiffusion pathway. Further, this activity is probably mediated directly by MSD2 as reaction of its single cysteine residue (Cys866) with the thiol modifying reagent, N(alpha)(3-maleimidylpropionyl)biocytin, inhibited chloride flux. Only MSD2 dimers were labelled by N(alpha)(3-maleimidylpropionyl)biocytin, supporting the idea that only dimeric MSD2 can mediate anion flux. As a further test of this hypothesis, we conducted a second purification procedure, wherein purified dimeric and monomeric MSD2 proteins were reconstituted separately. Only proteoliposomes containing stable MSD2 dimers mediated chloride electrodiffusion, providing direct evidence that dimeric MSD2 mediates chloride channel function. In summary, we have shown that the second membrane domain of CFTR can be purified and functionally reconstituted as a chloride channel, providing a tool for probing the structural basis of chloride conduction through CFTR.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12892562      PMCID: PMC1223717          DOI: 10.1042/BJ20030774

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

1.  A novel CFTR disease-associated mutation causes addition of an extra N-linked oligosaccharide.

Authors:  M M Hämmerle; A A Aleksandrov; X B Chang; J R Riordan
Journal:  Glycoconj J       Date:  2000-11       Impact factor: 2.916

2.  Molecular determinants of Au(CN)(2)(-) binding and permeability within the cystic fibrosis transmembrane conductance regulator Cl(-) channel pore.

Authors:  Xiandi Gong; Susan M Burbridge; Elizabeth A Cowley; Paul Linsdell
Journal:  J Physiol       Date:  2002-04-01       Impact factor: 5.182

3.  Arg352 is a major determinant of charge selectivity in the cystic fibrosis transmembrane conductance regulator chloride channel.

Authors:  R Guinamard; M H Akabas
Journal:  Biochemistry       Date:  1999-04-27       Impact factor: 3.162

4.  The E. coli BtuCD structure: a framework for ABC transporter architecture and mechanism.

Authors:  Kaspar P Locher; Allen T Lee; Douglas C Rees
Journal:  Science       Date:  2002-05-10       Impact factor: 47.728

5.  A monomer is the minimum functional unit required for channel and ATPase activity of the cystic fibrosis transmembrane conductance regulator.

Authors:  M Ramjeesingh; C Li; I Kogan; Y Wang; L J Huan; C E Bear
Journal:  Biochemistry       Date:  2001-09-04       Impact factor: 3.162

6.  Structure of MsbA from E. coli: a homolog of the multidrug resistance ATP binding cassette (ABC) transporters.

Authors:  G Chang; C B Roth
Journal:  Science       Date:  2001-09-07       Impact factor: 47.728

7.  Asymmetric structure of the cystic fibrosis transmembrane conductance regulator chloride channel pore suggested by mutagenesis of the twelfth transmembrane region.

Authors:  J Gupta; A Evagelidis; J W Hanrahan; P Linsdell
Journal:  Biochemistry       Date:  2001-06-05       Impact factor: 3.162

8.  CFTR: covalent and noncovalent modification suggests a role for fixed charges in anion conduction.

Authors:  S S Smith; X Liu; Z R Zhang; F Sun; T E Kriewall; N A McCarty; D C Dawson
Journal:  J Gen Physiol       Date:  2001-10       Impact factor: 4.086

9.  Direct block of the cystic fibrosis transmembrane conductance regulator Cl(-) channel by butyrate and phenylbutyrate.

Authors:  P Linsdell
Journal:  Eur J Pharmacol       Date:  2001-01-12       Impact factor: 4.432

10.  Severed molecules functionally define the boundaries of the cystic fibrosis transmembrane conductance regulator's NH(2)-terminal nucleotide binding domain.

Authors:  K W Chan; L Csanády; D Seto-Young; A C Nairn; D C Gadsby
Journal:  J Gen Physiol       Date:  2000-08       Impact factor: 4.086

View more
  4 in total

1.  Cystic fibrosis transmembrane conductance regulator interacts with multiple immunoglobulin domains of filamin A.

Authors:  Martin P Playford; Elisa Nurminen; Olli T Pentikäinen; Sharon L Milgram; John H Hartwig; Thomas P Stossel; Fumihiko Nakamura
Journal:  J Biol Chem       Date:  2010-03-29       Impact factor: 5.157

2.  Mutations at arginine 352 alter the pore architecture of CFTR.

Authors:  Guiying Cui; Zhi-Ren Zhang; Andrew R W O'Brien; Binlin Song; Nael A McCarty
Journal:  J Membr Biol       Date:  2008-04-18       Impact factor: 1.843

3.  Proteomic identification of calumenin as a G551D-CFTR associated protein.

Authors:  Ling Teng; Mathieu Kerbiriou; Mehdi Taiya; Sophie Le Hir; Olivier Mignen; Nathalie Benz; Pascal Trouvé; Claude Férec
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

4.  The ΔF508-CFTR mutation inhibits wild-type CFTR processing and function when co-expressed in human airway epithelia and in mouse nasal mucosa.

Authors:  Torry A Tucker; James A Fortenberry; Akos Zsembery; Lisa M Schwiebert; Erik M Schwiebert
Journal:  BMC Physiol       Date:  2012-09-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.